NVEC vs REGN · P/E 35, rev $25.9M vs P/E 14, rev $14.34B
NVE Corporation (NVEC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
NVE Corporation (NVEC) is a semiconductors company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported NVEC revenue for 2025-03-31 was $25.9M. Net income was $15.1M. Revenue was down 13.2% from 2024-03-31 to 2025-03-31. NVEC currently screens at market cap $527.6M and trailing P/E 34.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
NVEC currently screens at market cap $527.6M and trailing P/E 34.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the NVEC and REGN stock pages for the full models.
Not investment advice.